Trial Profile
A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2018
Price :
$35
*
At a glance
- Drugs Anthrax vaccine (Primary) ; Ciprofloxacin (Primary)
- Indications Anthrax
- Focus Pharmacokinetics; Registrational
- Sponsors Emergent BioSolutions
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 16 Apr 2014 Emergent BioSolutions has submitted the final clinical study report to the Biomedical Advanced Research and Development Authority (BARDA) and the US FDA.
- 16 Apr 2014 Primary endpoint 'Peak-drug-concentration' has been met.